166 related articles for article (PubMed ID: 30461653)
1. Association between polymorphisms in estrogen metabolism genes and breast cancer development in Chinese women: A prospective case-control study.
Qiu J; Du Z; Liu J; Zhou Y; Liang F; Lü Q
Medicine (Baltimore); 2018 Nov; 97(47):e13337. PubMed ID: 30461653
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P450 1B1 and catechol-O-methyltransferase genetic polymorphisms and breast cancer risk in Chinese women: results from the shanghai breast cancer study and a meta-analysis.
Wen W; Cai Q; Shu XO; Cheng JR; Parl F; Pierce L; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):329-35. PubMed ID: 15734954
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms in the catechol estrogen metabolism pathway and breast cancer risk.
Reding KW; Weiss NS; Chen C; Li CI; Carlson CS; Wilkerson HW; Farin FM; Thummel KE; Daling JR; Malone KE
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1461-7. PubMed ID: 19383894
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of breast cancer risk in a multigenic model including low penetrance genes involved in xenobiotic and estrogen metabolisms.
Delort L; Satih S; Kwiatkowski F; Bignon YJ; Bernard-Gallon DJ
Nutr Cancer; 2010; 62(2):243-51. PubMed ID: 20099199
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of catechol estrogens metabolism pathway genes and breast cancer risk in Mexican women.
Martínez-Ramírez OC; Pérez-Morales R; Castro C; Flores-Díaz A; Soto-Cruz KE; Astorga-Ramos A; Gonsebatt ME; Casas L; Valdés-Flores M; Rubio J
Breast; 2013 Jun; 22(3):335-43. PubMed ID: 23000097
[TBL] [Abstract][Full Text] [Related]
6. Soy isoflavones, CYP1A1, CYP1B1, and COMT polymorphisms, and breast cancer: a case-control study in southwestern China.
Wang Q; Li H; Tao P; Wang YP; Yuan P; Yang CX; Li JY; Yang F; Lee H; Huang Y
DNA Cell Biol; 2011 Aug; 30(8):585-95. PubMed ID: 21438753
[TBL] [Abstract][Full Text] [Related]
7. Estrogen metabolism genotypes, use of long-term hormone replacement therapy and risk of postmenopausal breast cancer.
Cerne JZ; Novakovic S; Frkovic-Grazio S; Pohar-Perme M; Stegel V; Gersak K
Oncol Rep; 2011 Aug; 26(2):479-85. PubMed ID: 21567099
[TBL] [Abstract][Full Text] [Related]
8. Association of single nucleotide polymorphisms in CYP1B1 and COMT genes with breast cancer susceptibility in Indian women.
Yadav S; Singhal NK; Singh V; Rastogi N; Srivastava PK; Singh MP
Dis Markers; 2009; 27(5):203-10. PubMed ID: 20037207
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in genes involved in the estrogen pathway and mammographic density.
Dumas I; Diorio C
BMC Cancer; 2010 Nov; 10():636. PubMed ID: 21092186
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450 CYP1B1 and catechol O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population.
Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Karakaya AE
Arch Toxicol; 2002 Nov; 76(11):643-9. PubMed ID: 12415427
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms and haplotype of hormone-related genes are associated with the risk of breast cancer in Chinese women.
Pan Z; Fu Z; Song Q; Cao W; Cheng W; Xu X
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323034
[TBL] [Abstract][Full Text] [Related]
12. Role of single nucleotide polymorphisms in estrogen-metabolizing enzymes and susceptibility to uterine leiomyoma in Han Chinese: a case-control study.
Shen Y; Xu Q; Ren M; Cai Y; Xu J
J Obstet Gynaecol Res; 2014 Apr; 40(4):1077-84. PubMed ID: 24320736
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms in estrogen-metabolizing genes and breast cancer survival.
Long JR; Cai Q; Shu XO; Cai H; Gao YT; Zheng W
Pharmacogenet Genomics; 2007 May; 17(5):331-8. PubMed ID: 17429315
[TBL] [Abstract][Full Text] [Related]
14. Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransferase 1A1, catechol-o-methyltransferase and tobacco exposure in breast cancer risk.
Saintot M; Malaveille C; Hautefeuille A; Gerber M
Int J Cancer; 2003 Nov; 107(4):652-7. PubMed ID: 14520706
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of estrogen synthesizing and metabolizing genes and breast cancer risk in Japanese women.
Miyoshi Y; Noguchi S
Biomed Pharmacother; 2003 Dec; 57(10):471-81. PubMed ID: 14637391
[TBL] [Abstract][Full Text] [Related]
16. Polymorphism in xenobiotic and estrogen metabolizing genes, exposure to perfluorinated compounds and subsequent breast cancer risk: A nested case-control study in the Danish National Birth Cohort.
Ghisari M; Long M; Røge DM; Olsen J; Bonefeld-Jørgensen EC
Environ Res; 2017 Apr; 154():325-333. PubMed ID: 28157646
[TBL] [Abstract][Full Text] [Related]
17. CYP17, catechol-o-methyltransferase, and glutathione transferase M1 genetic polymorphisms, lifestyle factors, and breast cancer risk in women on Prince Edward Island.
Cribb AE; Joy Knight M; Guernsey J; Dryer D; Hender K; Shawwa A; Tesch M; Saleh TM
Breast J; 2011; 17(1):24-31. PubMed ID: 21129090
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility.
Cheng TC; Chen ST; Huang CS; Fu YP; Yu JC; Cheng CW; Wu PE; Shen CY
Int J Cancer; 2005 Jan; 113(3):345-53. PubMed ID: 15455371
[TBL] [Abstract][Full Text] [Related]
19. Adipose tissue PCB levels and CYP1B1 and COMT genotypes in relation to breast cancer risk in postmenopausal Danish women.
Bräuner EV; Loft S; Wellejus A; Autrup H; Tjønneland A; Raaschou-Nielsen O
Int J Environ Health Res; 2014; 24(3):256-68. PubMed ID: 23869875
[TBL] [Abstract][Full Text] [Related]
20. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer.
Lavigne JA; Helzlsouer KJ; Huang HY; Strickland PT; Bell DA; Selmin O; Watson MA; Hoffman S; Comstock GW; Yager JD
Cancer Res; 1997 Dec; 57(24):5493-7. PubMed ID: 9407957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
